48Q Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - X4 Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 4.902 EUR

Market Cap: €823.2m

	X4 Pharmaceuticals Inc F:48Q	US
	Orchid Island Capital Inc F:45U0	US
L	Lepidico Ltd F:AUB	AU
	Nippon Suisan Kaisha Ltd F:71N	JP
	ValOre Metals Corp XTSX:VO	CA
	Embotelladora Andina SA F:AKOB	CL
M	Match Group Inc F:4MGN	US
M	Mitsubishi Chemical Holdings Corp OTC:MTLHY	JP
T	Teleperformance SE XMUN:RCF	FR
	Bavarian Nordic A/S F:BV3A	DK
	Critical Metals Corp F:9O2	AU
J	Judges Scientific PLC OTC:JSCIF	UK
T	Terumo Corp DUS:TUO	JP
	Reliance Worldwide Corporation Ltd F:0EU	AU

Profitability Summary

X4 Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

82%

Strong 3Y Average Gross Margin

74%

Negative Operating Margin

-1 084%

Negative 3Y Average Operating Margin

-5 139%

Negative Net Margin

-1 106%

Negative 3Y Average Net Margin

-213%

Negative Free Cash Flow Margin

-1 030%

Negative 3Y Average Free Cash Flow Margin

-5 103%

Negative ROE

-104%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-350%

ROIC is Increasing

-350% > -308%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.